PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME
France
01989170.4
Filed on 2001-12-05
01989170.4
Filed on 2001-12-05
PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME
Spain
01989170.4
Filed on 2001-12-05
01989170.4
Filed on 2001-12-05
PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME
Denmark
01989170.4
Filed on 2001-12-05
01989170.4
Filed on 2001-12-05
PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME
Germany
01989170.4
Filed on 2001-12-05
01989170.4
Filed on 2001-12-05
PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME
Switzerland
01989170.4
Filed on 2001-12-05
01989170.4
Filed on 2001-12-05
A Fullerene-based Anticoagulent
US Application 12/446,967
Filed on 2009-04-23
Filed on 2009-04-23
Asparagine Substitution To Prevent Deamidation Of IL-15Asparagine Substitution To Prevent Deamidation Of IL-15Asparagine
Patent Cooperation Treaty
PCT/US2009/042355
Filed on 2009-04-30
PCT/US2009/042355
Filed on 2009-04-30
A NOVEL ANTIPROLIFERATIVE FACTOR AND METHODS OF USE
Canada
2530803
Filed on 2004-07-01
2530803
Filed on 2004-07-01
Peptide Epitopes Of Vegfr-2/Kdr that Inhibit Angiogenesis
US Patent 8,378,071
Filed on 2009-03-11
Filed on 2009-03-11